Henrik Gregersen
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 45
- Multiple Myeloma Research and Treatments 43
- Genetics 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Henrik Toft Sørensen (10 shared papers)Niels Abildgaard (27 shared papers)Annette Juul Vangsted (25 shared papers)Niels Frost Andersen (20 shared papers)Tobias Wirenfeldt Klausen (21 shared papers)Peter Gimsing (18 shared papers)Henrik Hjalgrim (2 shared papers)Mads Melbye (1 shared paper)
In The Last Decade
Henrik Gregersen
74 papers receiving 2.6k citations
Henrik Gregersen's Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 1.5k
- Genetics 410
- Oncology 771
- Pathology and Forensic Medicine 253
- Molecular Biology 839
Countries citing papers authored by Henrik Gregersen
This map shows the geographic impact of Henrik Gregersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Gregersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Gregersen more than expected).
Fields of papers citing papers by Henrik Gregersen
This network shows the impact of papers produced by Henrik Gregersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Gregersen. The network helps show where Henrik Gregersen may publish in the future.
Co-authors
The 25 scholars most cited alongside Henrik Gregersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Hit paper breakdown → | 2019 | 516 |
| 2 | 2006 | 344 | |
| 3 | 1993 | 160 | |
| 4 | 2014 | 125 | |
| 5 | 2013 | 116 | |
| 6 | 2009 | 102 | |
| 7 | 2010 | 101 | |
| 8 | 2008 | 87 | |
| 9 | 2005 | 62 | |
| 10 | The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. | 2001 | 54 |
| 11 | 2016 | 54 | |
| 12 | 2015 | 54 | |
| 13 | 2001 | 53 | |
| 14 | 1998 | 53 | |
| 15 | 2015 | 49 | |
| 16 | 2006 | 40 | |
| 17 | 1998 | 39 | |
| 18 | 2000 | 37 | |
| 19 | 2018 | 36 | |
| 20 | 2017 | 36 |
About Henrik Gregersen
Henrik Gregersen is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Internal Medicine, having authored 78 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (43 papers), Cancer Treatment and Pharmacology (8 papers), Protein Degradation and Inhibitors (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Bone health and treatments (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (410 citations), Oncology (771 citations), Pathology and Forensic Medicine (253 citations) and Molecular Biology (839 citations). Henrik Gregersen has collaborated with scholars based in Denmark, Sweden and Norway. Frequent co-authors include Henrik Toft Sørensen, Niels Abildgaard, Annette Juul Vangsted, Niels Frost Andersen, Tobias Wirenfeldt Klausen, Peter Gimsing, Henrik Hjalgrim, Mads Melbye, Johan Askling and Ellen T. Chang. Their work appears in journals such as European Journal Of Haematology, Blood, British Journal of Haematology, Neurogastroenterology & Motility and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.